AMN Quote, Financials, Valuation and Earnings

Amedisys has a net margin of -25.53% compared to AMN Healthcare Services's net margin of 10.26%. AMN Healthcare Services's return on equity of -17.67% beat Amedisys's return on equity of 7.55%.

AMN Healthcare Services has a consensus price target of $28.57, signalling upside risk potential of 40.54%. On the other hand Amedisys has an analysts' consensus of $96.86 which suggests that it could grow by 1.74%. Given that AMN Healthcare Services has higher upside potential than Amedisys, analysts believe AMN Healthcare Services is more attractive than Amedisys.

AMN Healthcare Services has a beta of 0.159, which suggesting that the stock is 84.09% less volatile than S&P 500. In comparison Amedisys has a beta of 0.964, suggesting its less volatile than the S&P 500 by 3.612%.

AMN Healthcare Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMN Healthcare Services pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

AMN Healthcare Services quarterly revenues are $734.7M, which are larger than Amedisys quarterly revenues of $594.8M. AMN Healthcare Services's net income of -$187.5M is lower than Amedisys's net income of $61M. Notably, AMN Healthcare Services's price-to-earnings ratio is 18.72x while Amedisys's PE ratio is 35.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMN Healthcare Services is 0.26x versus 1.33x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

Health Catalyst has a net margin of -25.53% compared to AMN Healthcare Services's net margin of -29.9%. AMN Healthcare Services's return on equity of -17.67% beat Health Catalyst's return on equity of -20.06%.

AMN Healthcare Services has a consensus price target of $28.57, signalling upside risk potential of 40.54%. On the other hand Health Catalyst has an analysts' consensus of $8.27 which suggests that it could grow by 97.91%. Given that Health Catalyst has higher upside potential than AMN Healthcare Services, analysts believe Health Catalyst is more attractive than AMN Healthcare Services.

AMN Healthcare Services has a beta of 0.159, which suggesting that the stock is 84.09% less volatile than S&P 500. In comparison Health Catalyst has a beta of 1.559, suggesting its more volatile than the S&P 500 by 55.873%.

AMN Healthcare Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMN Healthcare Services pays -- of its earnings as a dividend. Health Catalyst pays out -- of its earnings as a dividend.

AMN Healthcare Services quarterly revenues are $734.7M, which are larger than Health Catalyst quarterly revenues of $79.4M. AMN Healthcare Services's net income of -$187.5M is lower than Health Catalyst's net income of -$23.7M. Notably, AMN Healthcare Services's price-to-earnings ratio is 18.72x while Health Catalyst's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMN Healthcare Services is 0.26x versus 0.84x for Health Catalyst. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health has a net margin of -25.53% compared to AMN Healthcare Services's net margin of 3.51%. AMN Healthcare Services's return on equity of -17.67% beat Option Care Health's return on equity of 15.22%.

AMN Healthcare Services has a consensus price target of $28.57, signalling upside risk potential of 40.54%. On the other hand Option Care Health has an analysts' consensus of $38.56 which suggests that it could grow by 21.63%. Given that AMN Healthcare Services has higher upside potential than Option Care Health, analysts believe AMN Healthcare Services is more attractive than Option Care Health.

AMN Healthcare Services has a beta of 0.159, which suggesting that the stock is 84.09% less volatile than S&P 500. In comparison Option Care Health has a beta of 0.763, suggesting its less volatile than the S&P 500 by 23.686%.

AMN Healthcare Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMN Healthcare Services pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.

AMN Healthcare Services quarterly revenues are $734.7M, which are smaller than Option Care Health quarterly revenues of $1.3B. AMN Healthcare Services's net income of -$187.5M is lower than Option Care Health's net income of $46.7M. Notably, AMN Healthcare Services's price-to-earnings ratio is 18.72x while Option Care Health's PE ratio is 25.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMN Healthcare Services is 0.26x versus 1.04x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of -25.53% compared to AMN Healthcare Services's net margin of -0.24%. AMN Healthcare Services's return on equity of -17.67% beat OptimizeRx's return on equity of -16.71%.

AMN Healthcare Services has a consensus price target of $28.57, signalling upside risk potential of 40.54%. On the other hand OptimizeRx has an analysts' consensus of $10.83 which suggests that it could grow by 9.32%. Given that AMN Healthcare Services has higher upside potential than OptimizeRx, analysts believe AMN Healthcare Services is more attractive than OptimizeRx.

AMN Healthcare Services has a beta of 0.159, which suggesting that the stock is 84.09% less volatile than S&P 500. In comparison OptimizeRx has a beta of 1.283, suggesting its more volatile than the S&P 500 by 28.349%.

AMN Healthcare Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMN Healthcare Services pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

AMN Healthcare Services quarterly revenues are $734.7M, which are larger than OptimizeRx quarterly revenues of $32.3M. AMN Healthcare Services's net income of -$187.5M is lower than OptimizeRx's net income of -$78K. Notably, AMN Healthcare Services's price-to-earnings ratio is 18.72x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMN Healthcare Services is 0.26x versus 1.97x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.